Chronic Kidney Disease (CKD) is common, silent for years, and often diagnosed too late. Simple blood and urine tests can catch early damage, and newer treatments like inhibitors and nonsteroidal MRAs can slow progression and reduce cardiovascular risks. Advocates argue that shifting from dialysis-focused care to prevention could save lives and long‑term costs.
Interest in broader screening is growing, especially as early detection becomes more actionable. Emerging studies suggest population screening starting around age 55 could be cost‑effective, but many clinicians still favor strengthening targeted screening first and fixing gaps in current care.
Is It Time for Universal CKD Screening?
